A global research team has identified a genetic variant linked to canine atopic dermatitis (cAD), a painful skin condition affecting up to 30 per cent of dogs.
Published in Frontiers in Veterinary Science, the study found that the SLAMF1 gene significantly increases the risk of developing the condition.
Dr James Barr, Chief Medical Officer of Mars Petcare Science and Diagnostics, said it is the first this gene has been connected to cAD.
“This is a huge step forward in pet care science and is a testament to how we’re able to leverage our global reach to help pets live healthier lives.”
The research was led by Wisdom Panel scientists in collaboration with Banfield Pet Hospital, Linnaeus, Mars Petcare Biobank, Waltham Petcare Science Institute and Antech Diagnostics.
It is the first study to use data from the Mars Petcare Biobank, launched in 2022 to help better understand disease development in cats and dogs.
Following the discovery, Wisdom Panel has developed a DNA test to identify the variant. The test will be offered in partnership with Canine Genetic Testing at the University of Cambridge’s Department of Veterinary Medicine to support breeding decisions that reduce cAD risk while maintaining genetic diversity.
To stay up to date on the latest industry headlines, sign up to the Pet Industry News e-newsletter.